|
|
||||
| Email This Page to Friend | |||||
Osteoarthritis is a degenerative form of arthritis. The joints in the body are composed of bone, which are covered with a smooth layer of cartilage. If you have a family history of osteoarthritis then you have a higher chance of developing the disease yourself. Besides genetic predisposition, osteoarthritis can be present in those who are overweight or those who routinely put stress on the particular joint. Injury is also a culprit.
Osteoarthritis affects the joints in the body, most commonly the spine, hips, knees, feet and hands. It is caused by the wearing down of cartilage between these joints, causing bones to rub together. This causes discomfort and a decrease in mobility to the area. Symptoms of osteoarthritis are generally limited to the joint involved. Patients usually experience pain when they use the joint and the symptoms go away with rest. Patients may have some stiffness, when they first use a joint. If the arthritis is severe, patients may lose functional capacity in the joint that has osteoarthritis.
Osteoarthritis is the most common form of arthritis, affecting 21 million people in the United States. It can be caused by a number of factors. While it is more frequently found in those over 45, it can occur in younger people. Under 45, men are more likely to develop the disease than women, while over 45 women are more likely to develop it than men.
Fortunately, there are ways to prevent the onset of the disease, and it's easier than you think. It's about taking care of your body, which hopefully you're doing already as good health is the key to combating any form of disease, as well as education.
If you are overweight you are far more likely to develop osteoarthritis than someone who isn't. This is because the extra weight puts unnecessary stress on the joints. Keeping in shape also helps to prevent many other diseases, such as heart disease.
Keep fit, not only to keep your weight in healthy range but also to work your joints. Aerobic exercises that work as much of your body are especially important; they revitalize your circulatory system and keep your heart rate up, as well as keep your joints limber. Make sure not to over exert yourself, especially if you feel pain in a joint, as this may only cause to exacerbate the condition you are trying to prevent. Discuss with your doctor what kinds of exercises are best for you. Osteoarthritis in the hands is the most genetically predispositioned form of the disease, so if you are at risk ask your doctor if there is anything you can do.
Injury to the joints can also cause the onset of osteoarthritis. Be sure to wear protective gear, like wrist guards for instance, when deemed necessary.
There have been some foods and supplements that have been reported to decrease your chances of getting the disease. While some initial results have proved encouraging, studies are still continuing for conclusive results. None of the supplements have been reported to carry side effects though, and are part of a healthy lifestyle.
An anti-inflammatory is just what you're looking for. Anti-inflammatory properties can be found in Omega-3 fatty acids, which are found in fatty fish like salmon or albacore tuna. Since our North American diet is severely lacking in fish on a regular basis, try an Omega-3 fatty acid supplement such as Omega Daily.
Early detection is important. If you feel a recurring pain in your joints, or a stiffness that won't go away, talk to your doctor. He or she can help you find the best way to deal with the pain.
Rheumatoid Arthritis, or RA, is an autoimmune disorder, causing your immune system to attack the joints, causing a painful inflammation. Unlike other forms of arthritis like osteoarthritis, RA also attacks the organs like the heart, eyes and lungs. Of the 100+ forms of arthritis, this is one of the most debilitating varieties.
Rheumatoid Arthritis affects 1 out of 100 North Americans, or 2.1 million people, and women are three times more likely to get the disease than men. The cause of RA is unknown, but a popular theory points to the disease being infectious as those who have close friends or family with the disorder are more likely to develop it themselves. Susceptibility to the disease may also be an inherited trait as well.
Early detection is vital in treating RA because the most damage is done within the first two years, with 75% of the damage occurring within the first five years. While there is no cure or preventative measure for rheumatoid arthritis, there are a number of treatments to alleviate symptoms. Each type of drug includes its own side effects- make sure that you are informed about the medication you are taking, and report any side effects to your doctor.
Non-Steroidal Anti-Inflammatory Drugs, or NSAIDs, reduce the pain and swelling of the joints. Many can be had without a prescription, like acetylsalicylic acid and ibuprofen. In more severe cases your doctor can prescribe a stronger NSAID. Omega-3, found in fatty fish, also works to shorten the period of stiffness in the morning, one of the major symptoms of rheumatoid arthritis. Add salmon or albacore tuna to your diet, or try an Omega-3 supplement like Omega Daily.
Disease-Modifying Anti-Rheumatic Drugs, known as DMARDs, are slow-acting and may take weeks to take effect. While NSAIDs are effective in relieving pain short term, DMARDs are a long term treatment meant to reduce damage to the joint and bone. Methotrexate is the most widely used DMARD.
There are a number of things you can do yourself to make living with the disease easier. While it is tempting to put as little exertion on your sore joints as possible, keeping active is essential to enjoying life with rheumatoid arthritis. This is for a number of reasons. The first is that regular exercise strengthens the muscles around the joint and increases flexibility. Try low-impact activities, like swimming. Try not to partake in any activities that involve too much exertion, which causes more harm than good. Use heat and cold to your advantage, easing pain. Heat should be applied only when the joint is not inflamed, and preferably in the form of a bath or hot shower. Use cold packs on the inflamed joint directly or after strenuous use of the joint.
|
Arthritis News
|
||||
|
9 Mar 2010 at 4:17pm Reuters - It may not be surprising, but a new study offers some proof that patients who are worried about their medications are more likely to have side effects from them. 8 Mar 2010 at 11:33am Reuters - Swiss drugmaker Roche Holding AG and U.S. biotechnology company Biogen Idec are suspending experimental rheumatoid arthritis and lupus treatment ocrelizumab after deaths following its use, casting doubt over its future. 6 Mar 2010 at 10:48pm HealthDay - SATURDAY, March 6 (HealthDay News) -- Electromagnetic pulses from a portable device can significantly reduce pain and inflammation in people suffering from osteoarthritis of the knee, a new study suggests. 25 Feb 2010 at 10:49pm HealthDay - THURSDAY, Feb. 25 (HealthDay News) -- Higher levels of obesity and inactivity, especially among women, explain why arthritis is more common in the United States than in Canada, according to a new study. |
11 Mar 2010 at 2:00am Christopher Evans, PhD, director of the Center for Advanced Orthopaedic Studies at Beth Israel Deaconess Medical Center (BIDMC) and Maurice Edmond Mueller Professor of Orthopaedic Surgery at Harvard Medical School, were presented with the 2010 Arthur Steindler Award at this week's annual meeting of the Orthopaedic Research Society in New Orleans... 11 Mar 2010 at 2:00am While physicians strive to set realistic expectations for patients undergoing knee and hip joint replacements, a new study reveals that doctor and patient expectations are sometimes not aligned... 8 Mar 2010 at 4:00am Electromagnetic pulses significantly decrease pain and inflammation associated with osteoarthritis of the knee, according to Henry Ford Hospital researchers... 4 Mar 2010 at 9:00pm NICE's independent appraisal committee has asked Roche, the manufacturer of tocilizumab (RoActemra), a new treatment for moderate to severe active rheumatoid arthritis, for further additional information on its product... 4 Mar 2010 at 4:00am The National Rheumatoid Arthritis Society (NRAS) has expressed their frustration at NICE's provisional decision not to allow patients with rheumatoid arthritis to routinely switch from one Anti-TNF drug to another. This is the second time NICE has appraised the sequential effectiveness of multiple biologic therapies following NRAS's successful appeal of negative NICE guidance on switching in 2007... 4 Mar 2010 at 4:00am Today the Arthritis and Musculoskeletal Alliance (ARMA), backed by leading policymakers and employers, is calling for positive action to ensure people with musculoskeletal disorders (MSDs) are properly supported to access employment and remain in their jobs... 4 Mar 2010 at 2:00am The National Institute for Health and Clinical Excellence (NICE) is currently appraising a number of drugs as possible treatments for rheumatoid arthritis after treatment with a tumour necrosis factor (TNF) inhibitor has failed. This is a part review of NICE technology appraisal guidance 36, and a review of NICE technology appraisal guidance 126 and 141... 3 Mar 2010 at 6:00am BioTrends Research Group released topline findings from LaunchTrends®: ACTEMRA, Wave 1, highlighting the market uptake of the product at one month post launch. Actemra (tocilizumab), marketed by Roche-Genentech, is a new IL-6 inhibitor with monthly dosing by IV infusion. The study results are based on an on-line survey completed by 77 rheumatologists in late February... 2 Mar 2010 at 6:00am New research has identified four aspects of immune system disturbance which lead to the development of coeliac disease. Nearly 40 different inherited risk factors which predispose to the disease have now been identified... 26 Feb 2010 at 8:00am A new study found that fluoxetine (Prozac®) and citalopram (Celexa®) treatment significantly inhibited disease progression of collagen-induced arthritis (CIA) in mice. Research led by Sandra Sacre, Ph.D... 26 Feb 2010 at 5:00am Researchers from the Toronto Western Research Institute noted a higher prevalence of arthritis and arthritis-attributable activity limitations (AAL) in the U.S. versus the Canadian population. The authors attribute the higher prevalence of arthritis and AAL to a greater level of obesity and physical inactivity in Americans, particularly women... 25 Feb 2010 at 12:00am Final guidance published today (Wednesday 24 February 2010) by the National Institute for Health and Clinical Excellence (NICE) means that another drug - certolizumab pegol (Cimzia) - can be considered for some people in England and Wales suffering with rheumatoid arthritis... 23 Feb 2010 at 3:00am CEL-SCI Corporation (NYSE CVM) and their scientific collaborators announced that the Company's CEL-2000 vaccine demonstrated that it is able to block the progression of rheumatoid arthritis (RA) in a mouse model... 23 Feb 2010 at 2:00am Enbrel is the trade name for Etanercept, a medication used for treating autoimmune diseases. Enbrel is a TNF (tumor necrosis factor) inhibitor; it interferes with TNF... 20 Feb 2010 at 3:00am At the core of the American College of Rheumatology Research and Education Foundation's mission is to attract the best and brightest trainees into a career in rheumatology. To do this, the REF has an extensive portfolio of awards and grants that provide support during critical career stages... |
10 Mar 2010 at 7:30am Treatment with anti-tumor necrosis factor (TNF) agents can significantly improve physical disability and quality of life for patients with psoriatic arthritis, data from an observational study showed 9 Mar 2010 at 10:22am Pain is common and can be severe in patients with systemic sclerosis, a Canadian cross-sectional analysis found. This is an underappreciated aspect of this disease. 8 Mar 2010 at 3:03pm Despite decades of dramatic advances in treatment of rheumatoid arthritis, survival has not improved for these patients, a Dutch study found. 5 Mar 2010 at 3:54pm NEW ORLEANS (MedPage Today) -- Why some patients with hereditary angioedema have suffered severe reactions to ecallantide (Kalbitor) in treating acute attacks remains a mystery, frustrating patients and physicians who had hoped the drug could be used at home. 5 Mar 2010 at 3:43pm Combination therapy with methotrexate and the tumor necrosis factor inhibitor etanercept (Enbrel) provided significantly greater clinical and radiographic benefits in early rheumatoid arthritis than treatment with methotrexate alone, an international double-blind study confirmed. 2 Mar 2010 at 1:53pm Treatment with hydroxychloroquine (Plaquenil) may help delay the occurrence of skin damage (MedPage Today) -- scarring alopecia, extensive scarring, and skin ulcers -- in patients with systemic lupus erythematosus, researchers said. 26 Feb 2010 at 11:00am Inflammatory disease activity in patients with systemic lupus erythematosus may be mediated by autoantibodies with the potential to influence development of the atherosclerosis underlying much of the mortality associated with the condition, researchers said. 26 Feb 2010 at 7:31am Group cognitive behavioral therapy may help patients with chronic or acute low-back pain, British researchers say. 25 Feb 2010 at 7:00am Americans, and particularly women, have a higher prevalence of arthritis and related activity limitations than their Canadian counterparts, possibly because they're more likely to be obese and inactive, a health survey found. 23 Feb 2010 at 8:01am Dynamic contrast-enhanced MRI revealed different patterns of inflammation between rheumatoid and psoriatic arthritis in the hands and wrists of afflicted patients, researchers found. 19 Feb 2010 at 10:28am Women with rheumatoid arthritis who inadvertently became pregnant while taking leflunomide were not at increased risk of giving birth to babies with major malformations, a prospective cohort study found. 15 Feb 2010 at 10:52am Short-term, high-dose cyclophosphamide appeared equivalent to the traditional lower dose monthly regimen for moderate-to-severe systemic lupus erythematosus, a prospective trial found. 15 Feb 2010 at 7:58am The greatest risk for atherosclerotic vascular events among patients with systemic lupus erythematosus is for men and older individuals of both sexes, analysis of a multinational cohort found. 11 Feb 2010 at 7:00am Low levels of physical activity were associated with increased subclinical atherosclerosis in women with systemic lupus erythematosus, a cross-sectional study found. 9 Feb 2010 at 11:16am SAN ANTONIO (MedPage Today) -- A personalized, online self-management program helped patients with pain syndromes improve coping skills and reduce stress and depression, according to results of two studies reported here. 10 Mar 2010 at 1:00am Title: Deep Vein Thrombosis (DVT) Category: Diseases and Conditions Created: 2/15/2000 10:55:00 PM Last Editorial Review: 3/10/2010 9 Mar 2010 at 1:00am Title: Treating Psoriasis If Enbrel Fails Category: Health News Created: 3/9/2010 10:10:00 AM Last Editorial Review: 3/9/2010 10:10:12 AM 8 Mar 2010 at 1:00am Title: Electromagnetic Pulses May Stem Arthritic Knee Pain Category: Health News Created: 3/6/2010 12:10:00 PM Last Editorial Review: 3/8/2010 5 Mar 2010 at 1:00am Title: Salmonella Scare Prompts Wide Product Recall Category: Health News Created: 3/4/2010 8:10:00 PM Last Editorial Review: 3/5/2010 5 Mar 2010 at 1:00am Title: Certain Bone Drugs May Lower Breast Cancer Risk Category: Health News Created: 3/5/2010 10:10:00 AM Last Editorial Review: 3/5/2010 3 Mar 2010 at 1:00am Title: Does Vitamin D Deficiency Cause Symptoms? Category: Doctor's Views Created: 3/3/2010 1:48:00 PM Last Editorial Review: 3/3/2010 1:48:43 PM 2 Mar 2010 at 1:00am Title: Liver Biopsy Category: Procedures and Tests Created: 12/31/1997 Last Editorial Review: 3/2/2010 2 Mar 2010 at 1:00am Title: Primary Care Doctors Ordering Unnecessary Scans Category: Health News Created: 3/1/2010 4:10:00 PM Last Editorial Review: 3/2/2010 1 Mar 2010 at 1:00am Title: Sprains and Strains Category: Diseases and Conditions Created: 3/5/2003 Last Editorial Review: 3/1/2010 26 Feb 2010 at 1:00am Title: Obesity, Lack of Exercise Heighten Arthritis Risk for Women Category: Health News Created: 2/25/2010 12:10:00 PM Last Editorial Review: 2/26/2010 25 Feb 2010 at 1:00am Title: Herpes Simplex Infections (Cold Sores, Non-Genital) Category: Diseases and Conditions Created: 6/16/1999 7:38:00 PM Last Editorial Review: 2/25/2010 25 Feb 2010 at 1:00am Title: New Bone Drug May Prevent Fractures But Raise Clot Risk Category: Health News Created: 2/24/2010 4:10:00 PM Last Editorial Review: 2/25/2010 |
by Arthritis News From Medical News Today 4 Mar 2010 at 8:00pm NICE's independent appraisal committee has asked Roche, the manufacturer of tocilizumab (RoActemra), a new treatment for moderate to severe active rheumatoid arthritis, for further additional information on its product... (Source: Arthritis News From Medical News Today) by Arthritis News From Medical News Today 4 Mar 2010 at 3:00am The National Rheumatoid Arthritis Society (NRAS) has expressed their frustration at NICE's provisional decision not to allow patients with rheumatoid arthritis to routinely switch from one Anti-TNF drug to another. This is the second time NICE has appraised the sequential effectiveness of multiple biologic therapies following NRAS's successful appeal of negative NICE guidance on switching in 2007... (Source: Arthritis News From Medical News Today) by Arthritis News From Medical News Today 4 Mar 2010 at 1:00am The National Institute for Health and Clinical Excellence (NICE) is currently appraising a number of drugs as possible treatments for rheumatoid arthritis after treatment with a tumour necrosis factor (TNF) inhibitor has failed. This is a part review of NICE technology appraisal guidance 36, and a review of NICE technology appraisal guidance 126 and 141... (Source: Arthritis News From Medical News Today) by Arthritis News From Medical News Today 3 Mar 2010 at 5:00am BioTrends Research Group released topline findings from LaunchTrends®: ACTEMRA, Wave 1, highlighting the market uptake of the product at one month post launch. Actemra (tocilizumab), marketed by Roche-Genentech, is a new IL-6 inhibitor with monthly dosing by IV infusion. The study results are based on an on-line survey completed by 77 rheumatologists in late February... (Source: Arthritis News From Medical News Today) by Arthritis News From Medical News Today 26 Feb 2010 at 7:00am A new study found that fluoxetine (Prozac®) and citalopram (Celexa®) treatment significantly inhibited disease progression of collagen-induced arthritis (CIA) in mice. Research led by Sandra Sacre, Ph.D... (Source: Arthritis News From Medical News Today) by Arthritis News From Medical News Today 24 Feb 2010 at 11:00pm Final guidance published today (Wednesday 24 February 2010) by the National Institute for Health and Clinical Excellence (NICE) means that another drug - certolizumab pegol (Cimzia) - can be considered for some people in England and Wales suffering with rheumatoid arthritis... (Source: Arthritis News From Medical News Today) by Arthritis News From Medical News Today 20 Feb 2010 at 2:00am At the core of the American College of Rheumatology Research and Education Foundation's mission is to attract the best and brightest trainees into a career in rheumatology. To do this, the REF has an extensive portfolio of awards and grants that provide support during critical career stages... (Source: Arthritis News From Medical News Today) by Arthritis News From Medical News Today 4 Feb 2010 at 3:00am Levels of inflammatory proteins, so-called cytokines, are elevated in the blood even before the onset of arthritic rheumatism... (Source: Arthritis News From Medical News Today) by Arthritis News From Medical News Today 3 Feb 2010 at 4:00am The U.S. Food and Drug Administration approved Xiaflex (collagenase clostridium histolyticum) as the first drug to treat a progressive hand disease known as Dupuytren's contracture, which can affect a person's ability to straighten and properly use their fingers. Dupuytren's contracture affects the connective tissue found beneath the skin in the palm of the hand... (Source: Arthritis News From Medical News Today) by Arthritis News From Medical News Today 2 Feb 2010 at 5:00am University of Queensland researchers have been part of a major breakthrough in understanding the cause of the debilitating arthritic condition ankylosing spondylitis (AS)... (Source: Arthritis News From Medical News Today) by Arthritis News From Medical News Today 31 Jan 2010 at 1:00am Investigators have identified a biomarker that could help doctors select patients with rheumatoid arthritis who will benefit from therapy with drugs such as Enbrel, a tumor necrosis factor (TNF)-antagonist drug... (Source: Arthritis News From Medical News Today) by Arthritis News From Medical News Today 28 Jan 2010 at 6:00am Researchers from University Hospital in Umea, Sweden, have identified several cytokines, cytokine-related factors, and chemokines that increase significantly prior to rheumatoid arthritis (RA) disease onset. These findings confirm those of earlier studies which suggest that the risk of developing RA can be predicted and disease progression may be prevented... (Source: Arthritis News From Medical News Today) by Arthritis News From Medical News Today 26 Jan 2010 at 9:00am Bristol-Myers Squibb Company (NYSE: BMY) announced that on 20 January 2010, the European Commission approved ORENCIA® (abatacept) in combination with methotrexate for the treatment of moderate to severe active polyarticular juvenile idiopathic arthritis (pJIA) in paediatric patients six years of age and older who have had an insufficient response to other DMARDS, including ... (Source: Arthritis News From Medical News Today) by Arthritis News From Medical News Today 22 Jan 2010 at 4:00am Final draft guidance published today (Thursday 21st January 2010) by the National Institute for Health and Clinical Excellence (NICE) will enable another therapy to be considered for some people in England, Wales and Northern Ireland suffering with rheumatoid arthritis. In the draft, certolizumab pegol is now recommended as a treatment option for some patients with the disease... (Source: Arthritis News From Medical News Today) by Arthritis News From Medical News Today 19 Jan 2010 at 3:00am MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) announced that it has enrolled the first patient in its Phase 1b/2a clinical trial of its lead drug MOR103... (Source: Arthritis News From Medical News Today) |
10 Mar 2010 at 10:27pm Reports of deaths from intravascular hemolysis after treatment with the immunoglobulin have prompted instructions for close monitoring for at least 8 hours after administration. Medscape Medical News 10 Mar 2010 at 10:03pm An independent consensus panel discussed their findings and implications after the National Institutes of Health Consensus Development Conference on VBAC. Medscape Medical News 10 Mar 2010 at 5:25pm Children suffering out-of-hospital cardiac arrests from noncardiac causes were more likely to have a good outcome if they received bystander CPR with rescue breathing, according to a new study. Heartwire 10 Mar 2010 at 5:01pm The authors of the study also suggest that ticagrelor may inhibit platelets more effectively than prasugrel. Heartwire 10 Mar 2010 at 4:24pm Study opens up possibility of new strategy in "herd immunity." Medscape Medical News 10 Mar 2010 at 4:17pm Infants with postrespiratory syncytial virus bronchiolitis have reduced eosinophil degranulation and fewer episodes of recurrent wheezing after montelukast treatment. Medscape Medical News 10 Mar 2010 at 3:28pm Quality of life is improved with the interleukin-12 inhibitor ustekinumab, including an improvement in sexual dysfunction, even in women. Medscape Medical News 10 Mar 2010 at 3:26pm Caregiver distress is significantly attenuated when Alzheimer's disease patients are treated with a combination of memantine plus a cholinesterase inhibitor vs cholinesterase inhibitor monotherapy. Medscape Medical News 10 Mar 2010 at 3:13pm The use of quetiapine is associated with more rapid onset of metabolic disturbances than other antipsychotics in elderly patients. Medscape Medical News 10 Mar 2010 at 2:36pm If the House concurs and President Obama signs the measure into law, it will be the third time in 4 months that lawmakers have postponed the reduction. Medscape Medical News 10 Mar 2010 at 2:16pm Access to medication has not improved among Medicare beneficiaries with depressive symptoms despite efforts to do with the introduction of Medicare Part D. Medscape Medical News 10 Mar 2010 at 1:49pm Electrical field could reduce corticol spreading depression involved in migraine with aura. Medscape Medical News 10 Mar 2010 at 12:37pm A Medicare analysis looking at 30-day mortality between hospitals offering PCI and those that don't hints that policy-makers looking to regionalize AMI care need to take into account what works and what doesn't at a local level. Heartwire 10 Mar 2010 at 12:37pm A new IVUS study has found that although the metabolic syndrome is associated with accelerated plaque progression, this can be attributed to its individual component risk factors rather than the syndrome itself. Heartwire 10 Mar 2010 at 12:17pm Nurse staffing levels, weekend admission, and seasonal influenza are also factors. Medscape Medical News |